Severe gastrointestinal complications in patients with levodopa/carbidopa intestinal gel infusion-Reference-Cited by-同舟云学术

Severe gastrointestinal complications in patients with levodopa/carbidopa intestinal gel infusion

Published:2012-11 Issue:13 Volume:27 Page:1704-1705
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov. Disord.

Author:

Klostermann Fabian,Jugel Constanze,Bömelburg Miriam,Marzinzik Frank,Ebersbach Georg,Müller Thomas

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mds.25238/fullpdf

Reference7 articles.

1. Randomized, double-blind, double-dummy study of continuous infusion of levodopa-carbidopa intestinal gel in patients with advanced Parkinson's disease: efficacy and safety;Olanow;Mov Disord,2012

2. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease;Nyholm;Neurology,2005

3. Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications;Olanow;Lancet Neurol,2006

4. The practice of gastrostomy tube placement across a Canadian regional health authority;Pruthi;Am J Gastroenterol,2010

5. Indications, complications, and long-term follow-up of patients undergoing percutaneous endoscopic gastrostomy: a retrospective study;Ermis;Wien Klin Wochenschr,2012

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endoscopic Complications Are More Frequent in Levodopa–Carbidopa Intestinal Gel Treatment via JET-PEG in Parkinson’s Disease Patients Compared to Nutritional PEG in Non-Parkinson’s Disease Patients;Journal of Clinical Medicine;2024-01-25

2. The role of istradefylline in the Parkinson’s disease armamentarium;Expert Opinion on Pharmacotherapy;2023-04-18

3. Acalculous cholecystitis associated with levodopa-carbidopa intestinal infusion therapy: A case report;Clinical Parkinsonism & Related Disorders;2022

4. Clinical Aspects of the Pharmacology and Biochemistry of Drugs for the Treatment of Motor Symptoms of Parkinson’s Disease;NeuroPsychopharmacotherapy;2022

5. The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on ‘Off’-time in Patients with Advanced Parkinson’s Disease: A Systematic Review;Advances in Therapy;2021-05-20